Effect of exenatide, sitagliptin, or glimepiride on β-cell secretory capacity in early type 2 diabetes.

Diabetes Care · 2014 · PMC4140159 · PMID 24969577

Europe PMC DOI

hedged sentence

0.1000

closest p · 2.0× alpha

0.1000

boldest claim

The sentences

a statistical trendP < 0.1so close (0.05 < p ≤ 0.1)

When a statistical trend ( P < 0.1) was evident with at least one of the between-group differences with glimepiride, within-group changes from baseline to final measures were compared with dependent Student t tests or the Wilcoxon matched-pairs test as appropriate.

also in 1,564 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.